CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...